ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,495, issued on Sept. 15, was assigned to CHIA TAI TIANQING PHARMACEUTICAL GROUP Co. LTD. (Jiangsu, China).
"Antibodies binding IL4R and uses thereof" was invented by Mingjiu Chen (Nanjing, China), Wei Tan (Nanjing, China), Cathy Xiaoyan Zhong (Nanjing, China), Mark Zhiqing Ma (Nanjing, China), Shukai Xia (Nanjing, China), Zhengping Zhang (Lianyungang, China), Hongjiang Xu (Lianyungang, China) and Zhijian Lu (Lianyungang, China).
According to the abstract* released by the U.S. Patent & Trademark Office: "An isolated monoclonal antibody that specifically binds human IL4RAlpha, or an antigen-binding portion thereof. A nucleic acid molecule encoding the antibody or the antigen-bindi...